Associated Papers
Mutational profile of the KIT gene and its heterogeneity in primary and metastatic melanomas.
Quintana Castillo JJA et al.
Journal of Cutaneous Pathology, 2026
Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon.
Incorvaia L et al.
Cancers, 2021
Case report: 16-yr life history and genomic evolution of an ER+ HER2- breast cancer.
Xu B et al.
Cold Spring Harbor Molecular Case Studies, 2020
33008833 (PubMed )
Supplement: supp_mcs.a005629_Supplemental_Files_1-5.pdf
Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P et al.
Nature, 2019
31645765 (PubMed )
Supplement: 41586_2019_1689_MOESM14_ESM.xlsx › Sheet1
Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.
Haenisch B et al.
Immunology, 2012
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
Molderings GJ et al.
Scandinavian Journal of Gastroenterology, 2007
Select a paper to view details